Haemonetics Analyst Price Targets - Benzinga

Haemonetics Corp

HAENYSE

Trade with Public

Trade with Public

$108.89

0.670.62%

Ult. Agg.: Aug 21, 11:04 AM

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

Haemonetics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Haemonetics (HAE).

Price Target Range — 12 Quarters

Analyst Consensus — 11 Analysts

1S.Buy

7Buy

3Hold

Consensus RatingOutperform# Analysts11Avg. Consensus PT$97Upside to Avg. PT-11.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 21, 2026	Baird	David Rescott	PT Raise	Outperform	$96→$119
Aug 19, 2026	Barrington Research	Michael Petusky	PT Raise	Outperform	$95→$118
Aug 18, 2026	BTIG	Marie Thibault	PT Raise	Buy	$96→$110
Aug 7, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$79→$92
Aug 7, 2026	JP Morgan	Allen Gong	PT Raise	Neutral	$62→$86
Aug 6, 2026	BTIG	Marie Thibault	PT Raise	Buy	$84→$96
Jul 15, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$85→$90
Jun 26, 2026	BTIG	Marie Thibault	Maintained	Buy	$84
Jun 17, 2026	BTIG	Marie Thibault	Maintained	Buy	$84
Jun 15, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$70→$85
May 28, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$64→$70
May 22, 2026	B of A Securities	Craig Bijou	Upgrade	Neutral→Buy	$72→$80
May 12, 2026	Barrington Research	Michael Petusky	PT Cut	Outperform	$94→$89
May 8, 2026	JP Morgan	Allen Gong	PT Cut	Neutral	$74→$62
Apr 13, 2026	Mizuho	Anthony Petrone	PT Cut	Outperform	$80→$70
Apr 7, 2026	Citigroup	Joanne Wuensch	PT Cut	Neutral	$70→$64
Mar 11, 2026	Citigroup	Joanne Wuensch	PT Cut	Neutral	$75→$70
Feb 6, 2026	Citigroup	Joanne Wuensch	PT Cut	Neutral	$88→$75
Feb 6, 2026	Mizuho	Anthony Petrone	PT Cut	Outperform	$90→$80
Feb 6, 2026	Barrington Research	Michael Petusky	PT Raise	Outperform	$93→$94

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Baird Maintains Outperform on Haemonetics, Raises Price Target to $119

Baird analyst David Rescott maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target from $96 to $119.

Benzinga Newsdesk

PRO
Barrington Research Maintains Outperform on Haemonetics, Raises Price Target to $118

Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target from $95 to $118.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Haemonetics, Raises Price Target to $110

BTIG analyst Marie Thibault maintains Haemonetics (NYSE:HAE) with a Buy and raises the price target from $96 to $110.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Haemonetics, Raises Price Target to $92

Citigroup analyst Joanne Wuensch maintains Haemonetics (NYSE:HAE) with a Neutral and raises the price target from $79 to $92.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Haemonetics, Raises Price Target to $86

JP Morgan analyst Allen Gong maintains Haemonetics (NYSE:HAE) with a Neutral and raises the price target from $62 to $86.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Haemonetics, Raises Price Target to $96

BTIG analyst Marie Thibault maintains Haemonetics (NYSE:HAE) with a Buy and raises the price target from $84 to $96.

Benzinga Newsdesk